City

New York (1)

Condition

Histiocytic Disorders (2)

Erdheim-Chester Disease (1)

Juvenile Xanthogranuloma (JXG) (1)

Langerhans Cell Histiocytosis (1)

Langerhans Cell Histiocytosis (LCH) (1)

Rosai-Dorfman Disease (RDD) (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Children's Hospital Medical Center, Cincinnati (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Intervention

biopsy (1)

f-choline pet scan (1)

fdg-pet (1)

mirdametinib (1)

Study Documents

Intervention Type

device (1)

drug (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

Histiocytic Disorders

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)

Not yet recruiting

Langerhans Cell Histiocytosis (LCH)
+3 more

Mirdametinib

(no location specified)

Nov 22, 2023

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic

Completed

Erdheim-Chester Disease
+2 more

F-choline PET Scan
+2 more

New York, New York

Memoral Sloan Kettering Cancer Center

Aug 28, 2018